986
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study

, , , , , , , , , , & show all
Pages 1227-1232 | Received 29 Mar 2016, Accepted 18 May 2016, Published online: 16 Jun 2016

References

  • Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490–1502.
  • Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–689.
  • Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med.2012;366:687–696.
  • Houlston RS. Colorectal cancer screening. Crit Rev Oncol Hematol. 1999;30:183–187.
  • Health Council of the Netherlands. A national colorectal cancer screening programme. The Hague: Health Council of the Netherlands; 2009; publication no. 2009/13E. ISBN 978-90-5549-780-5.
  • Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.
  • Binefa G, Rodriquez-Moranta F, Teule A, et al. Colorectal Cancer: from prevention to personalized medicine. World J Gastroenterol. 2014;20:6786–6808.
  • Whitlock EP, Lin J, Liles E, et al. Screening for colorectal cancer: an updated systematic review. Evidence Syntheses. No. 65.1, Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct. Report No.: 08-05-05124-EF-1.
  • De Jong AE, Vasen HF. The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med. 2006;64:367–370.
  • Ijspeert JE, Bevan R, Senore C, et al. Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview. Gut. 2016. doi: 10.1136/gutjnl-2015-310784.
  • Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96:2992–3003.
  • Dekker N, Hermens RP, Nagengast FM, et al. RISICO study group. Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives. Colorectal Dis. 2013;15:e175–e185.
  • Mesher D, Dove-Edwin I, Sasieni P, et al. A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer. Int J Cancer. 2014;134:939–947.
  • Van der Meulen-de Jong AE, Morreau H, Becx MC, et al. High detection rate of adenomas in familial colorectal cancer. Gut. 2011;60:73–76.
  • The RIVM [Internet] Available from: http://www.rivm.nl/Onderwerpen/B/Bevolkingsonderzoek_darmkanker/Wat_is_darmkanker. 2014.
  • Dove-Edwin I, Sasieni P, Adams J, et al. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ. 2005;331:1047
  • Jasperson KW, Tuohy TM, Neklason DW, et al. Hereditary and familial colon cancer. Gastroenterology. 2010;138:2044–2058.
  • Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999;116:1453–1456.
  • Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–932.
  • Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–268.
  • Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013;62:812–823.
  • Dutch guidelines MDL 2013. October 2014 [Internet]. Available from: http://ww.mdl.nl
  • Dekker N, van Rossum LG, van Vugt-van Pinxteren M, et al. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening. Eur J Cancer. 2011;47:1571–1577.
  • Worthley DL, Smith A, Bampton PA, et al. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Eur J Gastroenterol Hepatol. 2006;18:1079–1083.
  • Vasen HF, Möslein G, Alonso A, et al. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer. 2010;9:109–115.
  • Ten Broeke SW, Badal SS, van Wezel T, et al. Risk factors for the presence of pathogenic APC and biallelic MUTYH mutations in patients with multiple adenomas. Paper presented at: The 4th Joint Spring Conference; 2016; Cardiff, UK
  • Hennink SD, van der Meulen-de Jong AE, Wolterbeek R, et al. Randomized comparison of surveillance intervals in familial colorectal cancer. J Clin Oncol. 2015;10:4188–4193.